TSE:NBLY Neighbourly Pharmacy (NBLY) Stock Price, News & Analysis → The biggest energy story ever? (From Porter & Company) (Ad) Free NBLY Stock Alerts C$18.60 +0.06 (+0.32%) (As of 03/21/2024) Add Compare Share Share Today's RangeC$18.54▼C$18.6050-Day RangeC$18.26▼C$18.6052-Week RangeC$12.05▼C$23.00Volume816,808 shsAverage Volume283,112 shsMarket CapitalizationC$835.51 millionP/E RatioN/ADividend Yield0.97%Price TargetC$20.93 Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider Trades Get Neighbourly Pharmacy alerts: Email Address Neighbourly Pharmacy MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside12.5% UpsideC$20.93 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingAcquiring SharesC$1.16 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.76 out of 5 stars 2.2 Analyst's Opinion Consensus RatingNeighbourly Pharmacy has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageNeighbourly Pharmacy has only been the subject of 2 research reports in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for NBLY. Previous Next 0.0 Dividend Strength Dividend YieldNeighbourly Pharmacy has a dividend yield of 0.98%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthNeighbourly Pharmacy does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NBLY. Previous Next 2.0 News and Social Media Coverage News SentimentNeighbourly Pharmacy has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.35 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Neighbourly Pharmacy this week, compared to 1 article on an average week. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Neighbourly Pharmacy insiders have bought 1,980.15% more of their company's stock than they have sold. Specifically, they have bought C$1,158,350.00 in company stock and sold C$55,686.00 in company stock.Percentage Held by InsidersOnly 0.55% of the stock of Neighbourly Pharmacy is held by insiders.Percentage Held by Institutions65.88% of the stock of Neighbourly Pharmacy is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Neighbourly Pharmacy is -25.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Neighbourly Pharmacy is -25.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeighbourly Pharmacy has a P/B Ratio of 1.42. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About Neighbourly Pharmacy Stock (TSE:NBLY)Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.Read More NBLY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NBLY Stock News HeadlinesMay 1, 2024 | americanbankingnews.comNeighbourly Pharmacy (TSE:NBLY) Shares Up 0.3%March 23, 2024 | finanznachrichten.deNeighbourly Pharmacy Inc.: Neighbourly Announces Successful Closing of Take-Private Transaction with Persistence Capital PartnersMay 1, 2024 | The Freeport Society (Ad)Bill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…March 21, 2024 | finanznachrichten.deNeighbourly Pharmacy Inc.: Neighbourly Receives Final Court Approval of Plan of Arrangement to be Acquired by Persistence Capital PartnersMarch 20, 2024 | finance.yahoo.comNeighbourly Announces Successful Closing of Take-Private Transaction with Persistence Capital PartnersMarch 19, 2024 | finance.yahoo.comNeighbourly Pharmacy Inc.'s (TSE:NBLY) largest shareholders are private equity firms with 50% ownership, individual investors own 36%March 14, 2024 | finance.yahoo.comNeighbourly Receives Final Court Approval of Plan of Arrangement to be Acquired by Persistence Capital PartnersMarch 8, 2024 | marketwatch.comNeighbourly Pharmacy Holders Approve Deal to go PrivateMay 1, 2024 | The Freeport Society (Ad)Bill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…March 8, 2024 | finance.yahoo.comNeighbourly Obtains Shareholder Approval for Going Private Transaction with Persistence Capital PartnersFebruary 16, 2024 | ca.finance.yahoo.comNeighbourly Pharmacy Inc. (NBLY.TO)February 15, 2024 | finance.yahoo.comWhen Will Neighbourly Pharmacy Inc. (TSE:NBLY) Breakeven?February 13, 2024 | msn.comNeighbourly Pharmacy Inc. Non-GAAP EPS of C$0.19, revenue of C$284MFebruary 13, 2024 | finance.yahoo.comNeighbourly Announces Strong Third Quarter ResultsFebruary 12, 2024 | finance.yahoo.comNeighbourly Announces Filing of Special Meeting Materials and Receipt of Interim Order in Respect of Go-Private Arrangement with Persistence Capital PartnersFebruary 1, 2024 | finance.yahoo.comNeighbourly Announces Timing of Third Quarter 2024 Earnings ReleaseJanuary 23, 2024 | finance.yahoo.comNeighbourly Appoints Maura Dyer as Senior Vice President, People and CultureJanuary 15, 2024 | marketwatch.comNeighbourly Pharmacy Shares Rise 16% on Go-Private DealJanuary 15, 2024 | marketwatch.comNeighbourly Pharmacy Agrees to Go-Private Deal Worth C$415MJanuary 15, 2024 | msn.comPersistence Capital Partners signs deal to take Neighbourly Pharmacy privateJanuary 15, 2024 | finance.yahoo.comNeighbourly Enters into Definitive Agreement to go Private with its Controlling Shareholder Persistence Capital PartnersDecember 20, 2023 | theglobeandmail.comClosing Bell: Neighbourly Pharmacy Inc up on Wednesday (NBLY)December 19, 2023 | finance.yahoo.comNeighbourly Pharmacy's Market Cap Drops To CA$800m Leaving Insiders With LossesDecember 18, 2023 | theglobeandmail.comPersistence Capital Partners cuts buyout offer for Neighbourly PharmacyDecember 18, 2023 | marketwatch.comToronto Stocks Climb; Neighbourly Pharmacy Falls on Lowered Buyout OfferDecember 18, 2023 | marketwatch.comNeighbourly Pharmacy Shares Slide 12% on Lowered Buyout Price ProposalDecember 18, 2023 | finance.yahoo.comNeighbourly Provides Update on Proposal from Persistence Capital PartnersSee More Headlines Receive NBLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neighbourly Pharmacy and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/01/2024Next Earnings (Estimated)6/06/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolTSE:NBLY CUSIPN/A CIKN/A Webneighbourlypharmacy.ca Phone416 309 9102FaxN/AEmployees3,648Year FoundedN/APrice Target and Rating Average Stock Price TargetC$20.93 High Stock Price TargetC$28.00 Low Stock Price TargetC$18.50 Potential Upside/Downside+12.5%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.73) Trailing P/E RatioN/A Forward P/E Ratio24.77 P/E GrowthN/ANet IncomeC$-32,700,000.00 Net Margins-3.74% Pretax MarginN/A Return on Equity-5.34% Return on Assets0.74% Debt Debt-to-Equity Ratio58.29 Current Ratio1.14 Quick Ratio0.75 Sales & Book Value Annual SalesC$874.61 million Price / Sales0.96 Cash FlowC$0.60 per share Price / Cash Flow31.16 Book ValueC$13.07 per share Price / Book1.42Miscellaneous Outstanding Shares44,920,000Free FloatN/AMarket CapC$835.51 million OptionableNot Optionable Beta0.29 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Skip Bourdo (Age 46)CEO & Director Comp: $604.17kMr. Billy Wong C.M.A.CPA, M.B.A., Chief Financial OfficerMr. Jari Pekka Villanen (Age 53)Senior Vice President of Integration, Real Estate & Central Operations Comp: $307.48kMr. Steve Losty (Age 50)Chief Development Officer Comp: $302.15kMs. Maura DyerSenior Vice President of People & CultureMs. Alicia Matthews-KentSenior Vice President of Pharmacy Strategy & National OperationsMr. Zev ZelmanCorporate SecretaryMore ExecutivesKey CompetitorsWELL Health TechnologiesTSE:WELLHydropothecaryCVE:THCXSienna Senior LivingTSE:SIAAurora CannabisTSE:ACBExtendicareTSE:EXEView All CompetitorsInsidersRx Sidecar GP Inc.Bought 62,500 shares on 3/11/2024Total: C$1.16 M ($18.53/share)Stephen Richard LostySold 3,033 sharesTotal: C$55,685.88 ($18.36/share)Stephen Richard LostySold 2,711 sharesTotal: C$42,860.91 ($15.81/share)Stephen Richard LostySold 22,767 sharesTotal: C$404,489.91 ($17.77/share)View All Insider Transactions NBLY Stock Analysis - Frequently Asked Questions Should I buy or sell Neighbourly Pharmacy stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NBLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NBLY, but not buy additional shares or sell existing shares. View NBLY analyst ratings or view top-rated stocks. What is Neighbourly Pharmacy's stock price target for 2024? 5 analysts have issued 12 month price targets for Neighbourly Pharmacy's shares. Their NBLY share price targets range from C$18.50 to C$28.00. On average, they anticipate the company's share price to reach C$20.93 in the next year. This suggests a possible upside of 12.5% from the stock's current price. View analysts price targets for NBLY or view top-rated stocks among Wall Street analysts. How have NBLY shares performed in 2024? Neighbourly Pharmacy's stock was trading at C$16.79 at the beginning of 2024. Since then, NBLY shares have increased by 10.8% and is now trading at C$18.60. View the best growth stocks for 2024 here. When is Neighbourly Pharmacy's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, June 6th 2024. View our NBLY earnings forecast. How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy? Neighbourly Pharmacy declared a quarterly dividend on Monday, November 20th. Investors of record on Tuesday, December 19th will be paid a dividend of 0.045 per share on Tuesday, December 19th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date of this dividend is Monday, November 20th. Read our dividend analysis for NBLY. Is Neighbourly Pharmacy a good dividend stock? Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 0.98%. Read our dividend analysis for NBLY. How do I buy shares of Neighbourly Pharmacy? Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (TSE:NBLY) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyTrump just won 2024Porter & CompanyBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neighbourly Pharmacy Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.